Skip to main content
Erschienen in: Child's Nervous System 1/2014

01.01.2014 | Original Paper

Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis

verfasst von: Swetal Patel, Amit Bhatnagar, Christopher Wear, Stephen Osiro, Abigail Gabriel, David Kimball, Alana John, Paul J. Fields, R. Shane Tubbs, Marios Loukas

Erschienen in: Child's Nervous System | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Central nervous system tumors are the second most common form of cancer in children between the ages of 1 and 19 years. We aimed to provide the most recent data on the incidence and survival of these tumors in the USA and to assess the literature.

Methods

Frequency, rates, and survival sessions were calculated using the November 2008 submission for the US Surveillance Epidemiology and End Results Program. Data were collected and analyzed for children and adolescents aged 1 to 19 years with primary brain tumors.

Results

We found that the incidence rate of all pediatric brain tumors has been on a gradual but steady increase from 1973 to 2008 (p < 0.001). The average annual increase was 1.37 %. Our survival analysis of the individual tumors revealed that the 5-year overall survival for children diagnosed between 1974 and 1978 with medulloblastoma was 43.7 %. However, this increased to 62.8 % for children diagnosed between 1999 and 2003. A similar survival trend was also observed when all the other pediatric brain cancer histologies were collectively analyzed (p < 0.001).

Conclusions

From our study, we can conclude that contrary to previous reports indicating a plateau in the incidence rates of pediatric brain tumors since the mid-1980s, there has been an increase from 1973 to 2008. Potential causes include environmental carcinogens, but more research is needed to investigate the factors behind this sustained rise in incidence over the years.
Literatur
1.
Zurück zum Zitat Barnholtz-Sloan J, Sloan A, Schwartz A (2007) Cancer of the brain and other central nervous system. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (eds) SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, patient and tumor characteristics. National Cancer Institute, Bethesda, pp 203–216 Barnholtz-Sloan J, Sloan A, Schwartz A (2007) Cancer of the brain and other central nervous system. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (eds) SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, patient and tumor characteristics. National Cancer Institute, Bethesda, pp 203–216
2.
Zurück zum Zitat Bishop A, McDonald M, Chang A, Esiashvili N (2012) Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) data. Int J Radiat Oncol Biol Phys 82:341–347PubMedCrossRef Bishop A, McDonald M, Chang A, Esiashvili N (2012) Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) data. Int J Radiat Oncol Biol Phys 82:341–347PubMedCrossRef
3.
Zurück zum Zitat Bleyer W (1999) Epidemiologic impact of children with brain tumors. Childs Nerv Syst 15:758–763PubMedCrossRef Bleyer W (1999) Epidemiologic impact of children with brain tumors. Childs Nerv Syst 15:758–763PubMedCrossRef
4.
Zurück zum Zitat Buttarelli FR, Massimino M, Antonelli M, Lauriola L, Nozza P, Donofrio V, Arcella A, Oliva MA, Di Rocco C, Giangaspero F (2010) Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas. Childs Nerv Syst 26:1051–1056PubMedCrossRef Buttarelli FR, Massimino M, Antonelli M, Lauriola L, Nozza P, Donofrio V, Arcella A, Oliva MA, Di Rocco C, Giangaspero F (2010) Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas. Childs Nerv Syst 26:1051–1056PubMedCrossRef
6.
Zurück zum Zitat Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A et al (2011) Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma. OMICS 15:273–280PubMedCrossRef Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A et al (2011) Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma. OMICS 15:273–280PubMedCrossRef
8.
Zurück zum Zitat Deorah S, Lynch C, Sibenaller Z, Ryken T (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:1–7CrossRef Deorah S, Lynch C, Sibenaller Z, Ryken T (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:1–7CrossRef
9.
Zurück zum Zitat Gibbs I, Tuamokumo N, Yock T (2006) Role of radiation therapy in pediatric cancer. Hematol Oncol Clin N Am 20:455–470CrossRef Gibbs I, Tuamokumo N, Yock T (2006) Role of radiation therapy in pediatric cancer. Hematol Oncol Clin N Am 20:455–470CrossRef
10.
Zurück zum Zitat Gurney J (1999) Brain cancer incidence in children: time to look beyond the trends. Med Pediatr Oncol 33:110–112PubMedCrossRef Gurney J (1999) Brain cancer incidence in children: time to look beyond the trends. Med Pediatr Oncol 33:110–112PubMedCrossRef
11.
Zurück zum Zitat Inskip P, Linet M, Heineman E (1995) Etiology of brain tumors in adults. Epidemiol Rev 17:382–414PubMed Inskip P, Linet M, Heineman E (1995) Etiology of brain tumors in adults. Epidemiol Rev 17:382–414PubMed
12.
Zurück zum Zitat Joinpoint Regression Program, Version 3.5.2. October 2011; Statistical Research and Applications Branch, National Cancer Institute Joinpoint Regression Program, Version 3.5.2. October 2011; Statistical Research and Applications Branch, National Cancer Institute
13.
Zurück zum Zitat Kieran M, Walker D, Frappaz D, Prados M (2010) Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol 28:4783–4789PubMedCrossRef Kieran M, Walker D, Frappaz D, Prados M (2010) Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol 28:4783–4789PubMedCrossRef
14.
Zurück zum Zitat Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, Grundy R (2009) Pediatric ependymoma: biological perspectives. Mol Cancer Res 7:765–786PubMedCrossRef Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, Grundy R (2009) Pediatric ependymoma: biological perspectives. Mol Cancer Res 7:765–786PubMedCrossRef
15.
Zurück zum Zitat Knab B, Comell P (2007) Radiotherapy for pediatric brain tumors: when and how. Expert Rev Anticancer Ther 7:S69–S77PubMedCrossRef Knab B, Comell P (2007) Radiotherapy for pediatric brain tumors: when and how. Expert Rev Anticancer Ther 7:S69–S77PubMedCrossRef
16.
Zurück zum Zitat Küpeli S, Yalçin B, Bilginer B, Akalan N, Haksal P, Büyükpamukçu M (2011) Posterior fossa syndrome after posterior fossa surgery in children with brain tumors. Pediatr Blood Cancer 56:206–210PubMedCrossRef Küpeli S, Yalçin B, Bilginer B, Akalan N, Haksal P, Büyükpamukçu M (2011) Posterior fossa syndrome after posterior fossa surgery in children with brain tumors. Pediatr Blood Cancer 56:206–210PubMedCrossRef
17.
Zurück zum Zitat Legler J, Ries L, Smith M (1999) Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390PubMedCrossRef Legler J, Ries L, Smith M (1999) Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390PubMedCrossRef
18.
Zurück zum Zitat Linet M, Ries L, Smith M, Tarone R, Devesa S (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the USA. J Natl Cancer Inst 91:1051–1058PubMedCrossRef Linet M, Ries L, Smith M, Tarone R, Devesa S (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the USA. J Natl Cancer Inst 91:1051–1058PubMedCrossRef
19.
Zurück zum Zitat MacDonald SM, Trofimov A, Safai S, Adams J, Fullerton B, Ebb D, Tarbell NJ, Yock TI (2011) Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys 79:121–129PubMedCrossRef MacDonald SM, Trofimov A, Safai S, Adams J, Fullerton B, Ebb D, Tarbell NJ, Yock TI (2011) Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys 79:121–129PubMedCrossRef
20.
Zurück zum Zitat Mueller S, Chang S (2009) Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics 6:570–586PubMedCrossRef Mueller S, Chang S (2009) Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics 6:570–586PubMedCrossRef
21.
Zurück zum Zitat Musial-Bright L, Panteli L, Driever P (2011) Pediatric low-grade glioma survivors experience high quality of life. Childs Nerv Syst 27:1895–1902PubMedCrossRef Musial-Bright L, Panteli L, Driever P (2011) Pediatric low-grade glioma survivors experience high quality of life. Childs Nerv Syst 27:1895–1902PubMedCrossRef
22.
Zurück zum Zitat Rao A, Packer R (2012) Impact of molecular biology studies on the understanding of brain tumors in childhood. Curr Oncol Rep 14:206–212CrossRef Rao A, Packer R (2012) Impact of molecular biology studies on the understanding of brain tumors in childhood. Curr Oncol Rep 14:206–212CrossRef
23.
Zurück zum Zitat Rorke L, Gilles F, Davis R, Becker L (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1869–1886PubMedCrossRef Rorke L, Gilles F, Davis R, Becker L (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56:1869–1886PubMedCrossRef
24.
Zurück zum Zitat Schechter C (1999) Re: Brain and other central nervous system cancers: recent trends in incidence and mortality [Letter to the Editor]. J Natl Cancer Inst 92:77–78 Schechter C (1999) Re: Brain and other central nervous system cancers: recent trends in incidence and mortality [Letter to the Editor]. J Natl Cancer Inst 92:77–78
25.
Zurück zum Zitat Smith M, Freidlin B, Ries L, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277PubMedCrossRef Smith M, Freidlin B, Ries L, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277PubMedCrossRef
26.
Zurück zum Zitat Steen RG, Taylor JS, Langston JW, Glass JO, Brewer VR, Reddick WE, Mages R, Pivnick EK (2001) Prospective evaluation of the brain in asymptomatic children with neurofibromatosis Type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. Am J Neuroradiol 22:810–817PubMed Steen RG, Taylor JS, Langston JW, Glass JO, Brewer VR, Reddick WE, Mages R, Pivnick EK (2001) Prospective evaluation of the brain in asymptomatic children with neurofibromatosis Type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. Am J Neuroradiol 22:810–817PubMed
27.
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008) (Katrina/Rita population adjustment) Linked to county attributes - total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Surveillance, Epidemiology, and End Results (SEER) Program (www.​seer.​cancer.​gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2010 Sub (1973–2008) (Katrina/Rita population adjustment) Linked to county attributes - total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.
29.
30.
Zurück zum Zitat Villani A, Malkin D, Tabori U (2011) Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises. Curr Neurol Neurosci Rep 12:153–164CrossRef Villani A, Malkin D, Tabori U (2011) Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises. Curr Neurol Neurosci Rep 12:153–164CrossRef
31.
Zurück zum Zitat Werbowetski-Ogilvie T, Morrison L, Fiebig-Comyn A, Bhatia M (2011) In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 30:392–404CrossRef Werbowetski-Ogilvie T, Morrison L, Fiebig-Comyn A, Bhatia M (2011) In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 30:392–404CrossRef
32.
Zurück zum Zitat Wiegering V, Eyrich M, Rutkowski S, Wölfl M, Schlegel P, Winkler B (2011) TH1 predominance is associated with improved survival in pediatric medulloblastoma patients. Cancer Immunol Immunother 60:693–703PubMedCrossRef Wiegering V, Eyrich M, Rutkowski S, Wölfl M, Schlegel P, Winkler B (2011) TH1 predominance is associated with improved survival in pediatric medulloblastoma patients. Cancer Immunol Immunother 60:693–703PubMedCrossRef
33.
Zurück zum Zitat Wu XC, Chen VW, Steele B, Roffers S, Klotz JB, Correa CN, Carozza SE (2003) Cancer incidence in adolescents and young adults in the United States, 1992–1997. J Adolesc Health 32:405–415PubMedCrossRef Wu XC, Chen VW, Steele B, Roffers S, Klotz JB, Correa CN, Carozza SE (2003) Cancer incidence in adolescents and young adults in the United States, 1992–1997. J Adolesc Health 32:405–415PubMedCrossRef
Metadaten
Titel
Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis
verfasst von
Swetal Patel
Amit Bhatnagar
Christopher Wear
Stephen Osiro
Abigail Gabriel
David Kimball
Alana John
Paul J. Fields
R. Shane Tubbs
Marios Loukas
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 1/2014
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-013-2307-1

Weitere Artikel der Ausgabe 1/2014

Child's Nervous System 1/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.